Why Is Astrazeneca Willing To Spend a Whopping $12.1 Billion?
World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
New Technology Can Break The Blood-Brain Barrier To Directly Treat Brain Tumours, Is Potent And Less Toxic, And Deserves Attention!
Sudden Red Spots On Your Skin? Beware Of The "Undead Cancer", Be Alert To These Signs
New York Presbyterian University Hospital of Columbia and Cornell
"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial
